Patent · US Active

Compound for sequencing by synthesis

US9410197B2 · kind B2 · utility

5Cited by

2References

3Claims

0Family size

Assignee

Roche Molecular Systems, Inc. · US

Inventors

Frank Bergmann · Iffeldorf, DE
Dieter Heindl · Munich, DE
Jessica Steger-Domandl · Munich, DE

Key dates

Filing date	Nov 17, 2014
Grant date	Aug 9, 2016
Priority date	—
Expiry date	Mar 19, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/20
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides deoxynucleoside tri- or tetraphosphate comprising a 3′ nitrate and a detectable label covalently bound to the oxygen atom of an oxymethyl or oxyallyl or oxypropargyl substitution of a nucleobase. Such compounds provide new possibilities for future Sequencing by Synthesis technologies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.